Home Cart 0 Sign in  
X

[ CAS No. 445-28-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 445-28-3
Chemical Structure| 445-28-3
Chemical Structure| 445-28-3
Structure of 445-28-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 445-28-3 ]

Related Doc. of [ 445-28-3 ]

Alternatived Products of [ 445-28-3 ]

Product Details of [ 445-28-3 ]

CAS No. :445-28-3 MDL No. :MFCD00007970
Formula : C7H6FNO Boiling Point : -
Linear Structure Formula :- InChI Key :KGGHWIKBOIQEAJ-UHFFFAOYSA-N
M.W : 139.13 Pubchem ID :67964
Synonyms :

Calculated chemistry of [ 445-28-3 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 34.49
TPSA : 43.09 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.73 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.04
Log Po/w (XLOGP3) : 0.59
Log Po/w (WLOGP) : 1.34
Log Po/w (MLOGP) : 1.63
Log Po/w (SILICOS-IT) : 1.4
Consensus Log Po/w : 1.2

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.45
Solubility : 4.91 mg/ml ; 0.0353 mol/l
Class : Very soluble
Log S (Ali) : -1.07
Solubility : 11.9 mg/ml ; 0.0854 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.24
Solubility : 0.804 mg/ml ; 0.00578 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 445-28-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 445-28-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 445-28-3 ]
  • Downstream synthetic route of [ 445-28-3 ]

[ 445-28-3 ] Synthesis Path-Upstream   1~23

  • 1
  • [ 445-28-3 ]
  • [ 446-24-2 ]
Reference: [1] Chemische Berichte, 1937, vol. 70, p. 1416,1419
  • 2
  • [ 64-17-5 ]
  • [ 445-28-3 ]
  • [ 938-73-8 ]
YieldReaction ConditionsOperation in experiment
63% With potassium hydroxide In dimethyl sulfoxide at 20℃; for 16 h; General procedure: A mixture of 2-fluorobenzamide (1a, 69.5 mg, 0.5 mmol), MeOH (ca. 32.0 mg, 1.0 mmol), KOH (56.0 mg, 1.0 mmol) and DMSO (2.0 mL) in a 25 mL screw-capped thick-walled Pyrex tube was stirred at room temperature for 16 h, and then water (10 mL) was added to the reaction mixture with stirring, and the mixture was extracted with ethyl acetate three times (3 * 10 mL). The combined organic phases were dried over Na2SO4 overnight. The filtered solution was concentrated under reduced pressure, and the crude residue was purified by column chromatography on silica gel with the use of petroleum ether/ethyl acetate/trimethylamine (gradient mixture ratio from 6:1:0.05 to 2:1:0.05 in volume) to afford 2aa as a white solid in 80percent yield (60.7 mg).
Reference: [1] Tetrahedron, 2018, vol. 74, # 2, p. 303 - 307
[2] European Journal of Organic Chemistry, 2018, vol. 2018, # 39, p. 5382 - 5388
  • 3
  • [ 24652-66-2 ]
  • [ 445-28-3 ]
YieldReaction ConditionsOperation in experiment
83% With [(eta.(5)-pentamethylcyclopentadienyl)Ir(H2O)3](OTf)2 In water at 110℃; for 12 h; Schlenk technique 2-Fluorobenzaldehyde oxime (69.6 mg, 0.5 mmol), [Cp * Ir (H20) 3] [0Tf] 2 (5.lmg, 0.0075mmol, (Lml) were added sequentially to a 25 ml Schlenk reaction flask. The reaction mixture was allowed to react at 110 ° C for 12 hours and then cooled to room temperature. The water was removed by rotary evaporation, and the product was isolated by column chromatography. Yield: 83percent. ArH and 2xNH), 7. 54-7.50 (m, 1 H, ArH), 7. 29-7.25 (m (3 H, (D, JcF = 247.7 mmol), 132.4 (d, JcF = 8.8 Hz), 130.123 (d, J = 6.6 Hz, 1H) (D, JcF = 2.5Hz), 124.3 (d, JcF = 2.6Hz), 123.8 (d, JcF = 14.0Hz) 116.0 (d, JcF = 22). 5Hz).
Reference: [1] RSC Advances, 2016, vol. 6, # 43, p. 37093 - 37098
[2] Organometallics, 2012, vol. 31, # 17, p. 6482 - 6490
[3] Catalysis Science and Technology, 2014, vol. 4, # 4, p. 988 - 996
[4] Patent: CN104418682, 2016, B, . Location in patent: Paragraph 0047-0050
  • 4
  • [ 446-49-1 ]
  • [ 445-28-3 ]
YieldReaction ConditionsOperation in experiment
87% With tert.-butylhydroperoxide; ammonia; iodine In water at 100℃; for 3 h; Sealed tube; Green chemistry General procedure: A sealed tube equipped with a magnetic stirring bar was charged with ethylarene (1, 1.0 mmol), aq NH3 (2, 25percent aq solution,10.0 mmol), I2 (1.1 mmol), and TBHP (6.0 mmol, 70percent aq solution) at r.t. The resulting mixture was heated to 100 °C for 3.0 h. After completion of the reaction (monitored by TLC), sat.Na2S2O3 solution (10 mL) was added to the reaction mixture,and it was extracted with EtOAc (2 × 20 mL). The organic layer was washed with brine solution (20 mL), dried over anhydrous Na2SO4 and concentrated under reduced pressure. The residue was purified by column chromatography on 100–200 mesh silica gel using EtOAc–n-hexane (1:2) as the eluent to obtain the corresponding benzamide 3.
Reference: [1] Synlett, 2015, vol. 26, # 12, p. 1677 - 1682
  • 5
  • [ 394-47-8 ]
  • [ 445-28-3 ]
YieldReaction ConditionsOperation in experiment
83% With Acetaldehyde oxime; [(eta.(5)-pentamethylcyclopentadienyl)Rh(H2O)3](OTf)2 In water at 50℃; for 6 h; Schlenk technique A solution of 2-fluorobenzonitrile (121 mg, 1 mmol), [Cp * Rh (H2O)3] [OTf]2(3.0 mg, 0.005 mmol, 0.5 molpercent), acetaldehyde oxime (65 mg, 1.1 mmol) and water (1 ml) were successively added to a 25 ml Schlenk reaction flask.The reaction mixture was reacted at 50 ° C for 6 hours, then cooled to room temperature, and the water was removed by rotary evaporation to remove the title product. The yield was 83percent
Reference: [1] Tetrahedron Letters, 2010, vol. 51, # 12, p. 1589 - 1591
[2] RSC Advances, 2014, vol. 4, # 3, p. 1102 - 1106
[3] Journal of Organic Chemistry, 2015, vol. 80, # 8, p. 4148 - 4151
[4] New Journal of Chemistry, 2018, vol. 42, # 19, p. 15572 - 15577
[5] Catalysis Science and Technology, 2016, vol. 6, # 12, p. 4398 - 4409
[6] ChemSusChem, 2011, vol. 4, # 1, p. 104 - 111
[7] Chemistry - A European Journal, 2017, vol. 23, # 60, p. 15210 - 15221
[8] Chemistry - A European Journal, 2008, vol. 14, # 22, p. 6601 - 6605
[9] Chemistry - A European Journal, 2010, vol. 16, # 32, p. 9808 - 9817
[10] RSC Advances, 2014, vol. 4, # 108, p. 63466 - 63474
[11] Patent: CN104744288, 2017, B, . Location in patent: Paragraph 0040; 0041; 0042; 0043
[12] Organometallics, 2011, vol. 30, # 20, p. 5442 - 5451
[13] ChemCatChem, 2017, vol. 9, # 7, p. 1349 - 1353
[14] Tetrahedron Letters, 2000, vol. 41, # 19, p. 3747 - 3749
[15] Organometallics, 2010, vol. 29, # 17, p. 3955 - 3965
[16] ACS Catalysis, 2014, vol. 4, # 6, p. 1901 - 1910
[17] European Journal of Medicinal Chemistry, 1990, vol. 25, # 8, p. 673 - 680
[18] Journal of Medicinal Chemistry, 2009, vol. 52, # 17, p. 5295 - 5298
[19] Tetrahedron Letters, 2010, vol. 51, # 13, p. 1639 - 1641
[20] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 24, p. 5682 - 5686
  • 6
  • [ 393-52-2 ]
  • [ 445-28-3 ]
Reference: [1] Chemische Berichte, 1937, vol. 70, p. 1416,1419
[2] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 10, p. 2544 - 2546
[3] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 14, p. 3263 - 3270
  • 7
  • [ 446-52-6 ]
  • [ 445-28-3 ]
  • [ 445-29-4 ]
YieldReaction ConditionsOperation in experiment
24%
Stage #1: at -33℃; for 1 h; Inert atmosphere
Stage #2: at -33℃; for 1 h; Inert atmosphere; Reflux
General procedure: Under an argon atmosphere, liquid NH3 (25 mL) was condensedin a two-neck round-bottom flask immersed in a dry ice coolingbath and equipped with a dry ice reflux condenser. Aldehyde(7.34 mmol) was added, and the resulting solution (or suspension)was stirred for 1 h. KMnO4 (7.34 mmol, 1.16 g) was added,the cooling bath was removed, and the reaction mixture wasstirred for another hour with gentle reflux of NH3. Na2SO3 (22.0mmol, 2.78 g) was added, the reflux condenser was removed,and the NH3 was allowed to evaporate spontaneously. The darkbrownresidue was treated with 6 M HCl (30 mL), and theresulting precipitate was filtered, washed with H2O (100 mL)and sat. aq NaHCO3 (20 mL). All products were recrystallizedfrom EtOH.
24%
Stage #1: at -33℃; for 1 h; Inert atmosphere
Stage #2: for 1 h; Inert atmosphere; Reflux
General procedure: Under an argon atmosphere, liquid NH3 (25 mL) was condensedin a two-neck round-bottom flask immersed in a dry ice coolingbath and equipped with a dry ice reflux condenser. Aldehyde (7.34 mmol) was added, and the resulting solution (or suspension)was stirred for 1 h. KMnO4 (7.34 mmol, 1.16 g) was added,the cooling bath was removed, and the reaction mixture wasstirred for another hour with gentle reflux of NH3. Na2SO3 (22.0mmol, 2.78 g) was added, the reflux condenser was removed,and the NH3 was allowed to evaporate spontaneously. The darkbrownresidue was treated with 6 M HCl (30 mL), and theresulting precipitate was filtered, washed with H2O (100 mL)and sat. aq NaHCO3 (20 mL). All products were recrystallizedfrom EtOH.
Reference: [1] Synlett, 2014, vol. 25, # 9,
[2] Synlett, 2015, vol. 26, # 1, p. 84 - 86
  • 8
  • [ 389-31-1 ]
  • [ 445-28-3 ]
Reference: [1] Organic Letters, 2014, vol. 16, # 2, p. 624 - 627
  • 9
  • [ 766-49-4 ]
  • [ 445-28-3 ]
Reference: [1] Tetrahedron Letters, 2009, vol. 50, # 24, p. 2973 - 2975
[2] Advanced Synthesis and Catalysis, 2016, vol. 358, # 3, p. 500 - 505
  • 10
  • [ 446-52-6 ]
  • [ 445-28-3 ]
Reference: [1] RSC Advances, 2016, vol. 6, # 43, p. 37093 - 37098
[2] Organometallics, 2012, vol. 31, # 17, p. 6482 - 6490
  • 11
  • [ 445-27-2 ]
  • [ 445-28-3 ]
Reference: [1] Organic and Biomolecular Chemistry, 2014, vol. 12, # 33, p. 6359 - 6362
  • 12
  • [ 348-52-7 ]
  • [ 445-28-3 ]
Reference: [1] RSC Advances, 2015, vol. 5, # 9, p. 6636 - 6641
  • 13
  • [ 446-52-6 ]
  • [ 394-47-8 ]
  • [ 445-28-3 ]
Reference: [1] RSC Advances, 2013, vol. 3, # 17, p. 5889 - 5894
  • 14
  • [ 75-64-9 ]
  • [ 445-29-4 ]
  • [ 445-28-3 ]
  • [ 61752-07-6 ]
Reference: [1] Organic Letters, 2010, vol. 12, # 10, p. 2406 - 2409
  • 15
  • [ 24652-66-2 ]
  • [ 394-47-8 ]
  • [ 445-28-3 ]
Reference: [1] Synthetic Communications, 2013, vol. 43, # 13, p. 1778 - 1786
  • 16
  • [ 66896-69-3 ]
  • [ 445-28-3 ]
Reference: [1] Chemistry - A European Journal, 2007, vol. 13, # 23, p. 6590 - 6594
  • 17
  • [ 445-29-4 ]
  • [ 445-28-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 10, p. 2544 - 2546
[2] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 14, p. 3263 - 3270
[3] Patent: CN105541753, 2016, A, . Location in patent: Paragraph 0007;
  • 18
  • [ 201230-82-2 ]
  • [ 348-52-7 ]
  • [ 445-28-3 ]
Reference: [1] ChemCatChem, 2017, vol. 9, # 22, p. 4206 - 4211
  • 19
  • [ 89-99-6 ]
  • [ 445-28-3 ]
Reference: [1] Journal of Organic Chemistry, 2018, vol. 83, # 1, p. 260 - 266
  • 20
  • [ 57-13-6 ]
  • [ 445-29-4 ]
  • [ 445-28-3 ]
Reference: [1] Pharmaceutical Chemistry Journal, 1994, vol. 28, # 5, p. 335 - 338[2] Khimiko-Farmatsevticheskii Zhurnal, 1994, vol. 28, # 5, p. 35 - 37
  • 21
  • [ 55-21-0 ]
  • [ 445-28-3 ]
  • [ 18355-75-4 ]
  • [ 85118-04-3 ]
Reference: [1] Russian Journal of Organic Chemistry, 2004, vol. 40, # 4, p. 513 - 517
  • 22
  • [ 443-26-5 ]
  • [ 445-28-3 ]
Reference: [1] Zeitschrift fuer Physikalische Chemie (Leipzig), 1930, vol. <B> 10, p. 106,119
  • 23
  • [ 445-28-3 ]
  • [ 399-31-5 ]
Reference: [1] Chemische Berichte, 1937, vol. 70, p. 1416,1419
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 445-28-3 ]

Fluorinated Building Blocks

Chemical Structure| 85118-02-1

[ 85118-02-1 ]

2,4-Difluorobenzamide

Similarity: 0.98

Chemical Structure| 518057-72-2

[ 518057-72-2 ]

5-Amino-2-fluorobenzamide

Similarity: 0.91

Chemical Structure| 446-24-2

[ 446-24-2 ]

2-Fluorobenzohydrazide

Similarity: 0.91

Chemical Structure| 824-75-9

[ 824-75-9 ]

4-Fluorobenzamide

Similarity: 0.90

Chemical Structure| 455-37-8

[ 455-37-8 ]

3-Fluorobenzamide

Similarity: 0.88

Aryls

Chemical Structure| 85118-02-1

[ 85118-02-1 ]

2,4-Difluorobenzamide

Similarity: 0.98

Chemical Structure| 518057-72-2

[ 518057-72-2 ]

5-Amino-2-fluorobenzamide

Similarity: 0.91

Chemical Structure| 446-24-2

[ 446-24-2 ]

2-Fluorobenzohydrazide

Similarity: 0.91

Chemical Structure| 824-75-9

[ 824-75-9 ]

4-Fluorobenzamide

Similarity: 0.90

Chemical Structure| 455-37-8

[ 455-37-8 ]

3-Fluorobenzamide

Similarity: 0.88

Amides

Chemical Structure| 85118-02-1

[ 85118-02-1 ]

2,4-Difluorobenzamide

Similarity: 0.98

Chemical Structure| 518057-72-2

[ 518057-72-2 ]

5-Amino-2-fluorobenzamide

Similarity: 0.91

Chemical Structure| 446-24-2

[ 446-24-2 ]

2-Fluorobenzohydrazide

Similarity: 0.91

Chemical Structure| 824-75-9

[ 824-75-9 ]

4-Fluorobenzamide

Similarity: 0.90

Chemical Structure| 455-37-8

[ 455-37-8 ]

3-Fluorobenzamide

Similarity: 0.88

Amines

Chemical Structure| 85118-02-1

[ 85118-02-1 ]

2,4-Difluorobenzamide

Similarity: 0.98

Chemical Structure| 518057-72-2

[ 518057-72-2 ]

5-Amino-2-fluorobenzamide

Similarity: 0.91

Chemical Structure| 446-24-2

[ 446-24-2 ]

2-Fluorobenzohydrazide

Similarity: 0.91

Chemical Structure| 824-75-9

[ 824-75-9 ]

4-Fluorobenzamide

Similarity: 0.90

Chemical Structure| 455-37-8

[ 455-37-8 ]

3-Fluorobenzamide

Similarity: 0.88